Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prostate Cancer, High Cortisol Levels and Complex Hormonal Interaction

  • Fabre, Bibiana (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires) ;
  • Grosman, Halina (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires) ;
  • Gonzalez, Diego (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires) ;
  • Machulsky, Nahuel Fernandez (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires) ;
  • Repetto, Esteban M (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires) ;
  • Mesch, Viviana (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires) ;
  • Lopez, Miguel Angel (Urology Division, Hospital de Clinicas. Universidad de Buenos Aires) ;
  • Mazza, Osvaldo (Urology Division, Hospital de Clinicas. Universidad de Buenos Aires) ;
  • Berg, Gabriela (Clinical Biochemistry Department, INFIBIOC, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires)
  • Published : 2016.07.01
⟨ Previous Next ⟩

Abstract

Prostate cancer (PCa) is one of the most common diseases in men. It is important to assess prognostic factors and whether high cortisol levels and complex hormonal interactions could be responsible for PCa development. We evaluated the relationship between cortisol, leptin and estrogens in 141 men, 71 with PCa and the remaining 70 constituting a low risk group (LRG). They were recruited for this study from a total of 2906 middle-aged men (ages 45-70 years) who completed an evaluation for prostatic diseases at the Urology Division, Hospital de Clínicas "$Jos{\acute{e}}$ de San $Mart{\acute{i}}n$", University of Buenos Aires, in May 2009. In this cross sectional study, cortisol, PSA, total-testosterone, free-testosterone, bioavailable testosterone, LH and estradiol were measured in serum. We observed increased cortisol levels in PCa patients as compared to LRG cases (p=0.004,). Leptin and estradiol levels were also higher in PCa patients (p=0.048; p<0.0001, respectively). Logistic regression analysis indicated that serum cortisol (OR: 1.110 (95% CI 1.016-1.213), p=0.022), estradiol (OR: 1.044 (95% CI 1.008-1.081), p=0.016) and leptin (OR: 1.248 (95% CI 1.048-1.487), p=0.013) explained 27% of the variance of dependent variables, even after adjusting for age, smoking, BMI and waist circumference. We found increased cortisol levels in PCa patients as compared to LRG, as well as an altered circulating hormonal profile.

Keywords

References

  1. Antoni M, Lutgendorf S, Cole S, et al (2006). The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer, 6, 240-248. https://doi.org/10.1038/nrc1820
  2. Antonova L, Aronson K, Mueller C, (2011). Stress and breast cancer: from epidemiology to molecular biology. Breast Cancer Res, 13, 208. https://doi.org/10.1186/bcr2836
  3. Ben-Eliyahu S, Shakhar G, Page G, et al (2000). Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation, 8, 154-164 https://doi.org/10.1159/000054276
  4. Bradlow H, Sepkovic D, (2004). Steroids as procarcinogenic agents. Ann N Y Acad Sci, 1028, 216-32. https://doi.org/10.1196/annals.1322.027
  5. Carruba, G, 2006. Estrogens and mechanisms of prostate cancer progression. Ann N Y Acad Sci, 1089, 201-217. https://doi.org/10.1196/annals.1386.027
  6. Chida Y, Steptoe A, (2008). Positive psychological wellbeing and mortality: a quantitative review of prospective observational studies. Psychosom Med, 70, 741-756. https://doi.org/10.1097/PSY.0b013e31818105ba
  7. Dagogo-Jack S, (2001). Human leptin regulation and promise in pharmacotherapy. Curr Drug Targets, 2, 181-95. https://doi.org/10.2174/1389450013348623
  8. Dieudonne M, Sammari A, Dos Santos E, et al (2006). Sex steroids and leptin regulate 11-hydroxysteroid dehydrogenase 1 and p450 aromatase expressions in human preadipocytes: sex specificities. J Steroid Biochem Mol Biol, 99, 189-196. https://doi.org/10.1016/j.jsbmb.2006.01.007
  9. Dubois V, Jarde T, Delort L, et al (2014). Leptin induces a proliferative response in breast cancer cells but not in normal breast cells. Nutr Cancer, 66, 645-55 https://doi.org/10.1080/01635581.2014.894104
  10. Fabre B, Machulsky N, Grosman H, et al (2014). Life events are positively associated with luteinizing hormone in middle age adult men. Role of cortisol as a third variable. Stress, 17, 328-33. https://doi.org/10.3109/10253890.2014.930431
  11. Fleshner N, Zlotta A, (2007). Prostate cancer prevention: past, present, and future. Cancer, 110, 1889-99. https://doi.org/10.1002/cncr.23009
  12. Fradet V, Cheng I, Casey G, et al (2009). Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res, 15, 2559-66. https://doi.org/10.1158/1078-0432.CCR-08-2503
  13. Freedland S, Aronson W, (2009). Dietary intervention strategies to modulate prostate cancer risk and prognosis. Curr Opin Urol, 19, 263-7. https://doi.org/10.1097/MOU.0b013e328329ea6c
  14. Garssen B (2004). Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev, 24, 315-38. https://doi.org/10.1016/j.cpr.2004.01.002
  15. Gidron Y, Fabre B, Grosman H, et al (2011). Life events, cortisol and levels of prostate specific antigen: A story of synergism. Psychoneuroendocrinol, 36, 874-80. https://doi.org/10.1016/j.psyneuen.2010.11.011
  16. Gleason D (1992). Histologic grading of prostate cancer; a perspective. Hum Pathol, 23, 273-79. https://doi.org/10.1016/0046-8177(92)90108-F
  17. Hammarsten J, Damber J, Karlsson M, et al (2009). Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis, 12, 160-5. https://doi.org/10.1038/pcan.2008.50
  18. Masuzaki H, Ogawa Y, Hosoda K, et al (1997). Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab, 82, 2542-7.
  19. McMurtry V, Simeone A, Nieves-Alicea R, et al (2009). Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin Exp Metastasis, 26, 197-204. https://doi.org/10.1007/s10585-008-9231-x
  20. Mravec B, Gidron Y, Hulin I, 2008. Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain. Semin Cancer Biol, 18, 150-163. https://doi.org/10.1016/j.semcancer.2007.12.002
  21. Pasquali R, Vicennati V, Cacciari M et al (2006). The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci, 1083, 111-128. https://doi.org/10.1196/annals.1367.009
  22. Ray A, Nkhata K, Cleary M, (2007). Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol, 30, 1499-509.
  23. Risbridger G, Bianco J, Ellem S, et al (2003). Oestrogens and prostate cancer. Endocr Relat Cancer, 10, 187-191. https://doi.org/10.1677/erc.0.0100187
  24. Shaikh M, Grundy R, Kirk J, (2008). Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. Eur J of Endocrinol, 159, 791-7. https://doi.org/10.1530/EJE-08-0533
  25. Simpson E, (2000). Biology of aromatase in the mammary gland. J Mammary Gland Biol Neoplasia, 5, 251-258. https://doi.org/10.1023/A:1009590626450
  26. Slieker L, Sloop K, Surface P, et al (1996). Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem, 271, 5301-4. https://doi.org/10.1074/jbc.271.10.5301
  27. Turnbull A, Rivier C, (1999). Regulation of the hypothalamicpituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev, 79, 1-71. https://doi.org/10.1152/physrev.1999.79.1.1
  28. Chou Y, Chou W, Hsu G, et al (2009). Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer, 100, 578-582. https://doi.org/10.1038/sj.bjc.6604913
  29. Vermeulen A, Verdonck L, Kaufman J, (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab, 84, 3666-72. https://doi.org/10.1210/jcem.84.10.6079
  30. Wiklund F, Lageros Y, Chang E, et al (2008). Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden. Eur J Epidemiol, 23, 739-46 https://doi.org/10.1007/s10654-008-9294-7
  31. Williams G, (2012). Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant $ER-{\alpha}$ and GPER signaling. Mol Cell Endocrinol, 351, 269-78. https://doi.org/10.1016/j.mce.2011.12.017
  32. Williams G, (2010). The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur J Cancer Prev, 19, 256-71. https://doi.org/10.1097/CEJ.0b013e328338f7d2